Shares of Jubilant Life Sciences on Friday dropped nearly 4 per cent after the company reported a 23.97 per cent fall in consolidated net profit for the third quarter ended on December 31, 2019.
The scrip declined 3.55 per cent to close at Rs 581.95 on the BSE. During the day, it plunged 5.14 per cent to Rs 572.35.
On the NSE, it fell 3.89 per cent to close at Rs 579.20.
Drug firm Jubilant Life Sciences on Friday reported a 23.97 per cent fall in consolidated net profit at Rs 203.38 crore for the third quarter ended on December 31, 2019.
It had posted a net profit of Rs 267.52 crore in the October-December quarter a year ago, Jubilant Life Sciences said in a BSE filing.
Net sales during the quarter under review stood at Rs 2,279.89 crore, down 3.11 per cent, as against Rs 2,353.08 crore in the corresponding period a year ago.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
